New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

FDA Warns Against Fake Alzheimer’s Cures

The FDA condemns companies that claim their products can prevent, treat, delay, or even cure Alzheimer’s disease without proof.

Alzheimer's 'Cures' / Image: FDA
Alzheimer's "Cures" / Image: FDA

A recent consumer update from the FDA warned against unproven treatments for Alzheimer’s disease. As the elderly population grows in America, the number of people affected by Alzheimer’s also increases, creating a high demand for treatments. While serious research and development is taking place to find a cure, there’s no shortage of companies looking to cash with products that make false claims. Most often these products are sold online and falsely labeled as dietary supplements.

The FDA wants consumers to remember the saying, ‚Äúif it seems too good to be true, it probably is.‚ÄĚ They also warn against any product that claims to be a ‚Äúscientific breakthrough‚ÄĚ and suggest consulting a doctor before buying any OTC products. Patients interested in the latest clinical research and testing can participate in clinical trials. In the meantime, the FDA continues to take action against companies making false claims about treating Alzheimer‚Äôs.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts